These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5285743)

  • 21. Incidence of the Philadelphia chromosome and other chromosomic disturbances in adults with chronic myelocytic leukemia.
    Zapata-Gayón N; Arechavala-Perichard E; Pizzuto J; Cea-Cerros GA; González-Angulo A
    Arch Invest Med (Mex); 1982; 13(1):33-6. PubMed ID: 6950691
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and laboratory characteristics of terminal chronic myeloid leukemia (author's transl)].
    Lukásová M; Sedácková M
    Cas Lek Cesk; 1980 Sep; 119(38):1018-22. PubMed ID: 6937264
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidemiologic aspects of chronic myeloleukosis].
    Plotnikov IuK
    Probl Gematol Pereliv Krovi; 1976 Nov; 21(11):29-33. PubMed ID: 139607
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-statistical review of 26 cases of chronic myeloid leukemia].
    Marzani MC; Guaschino R
    Clin Ter; 1982 Aug; 102(4):403-7. PubMed ID: 6958404
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chronic myelogenous leukemia. Acute transformation].
    Uzuka Y
    Rinsho Ketsueki; 1984 Mar; 25(3):288-98. PubMed ID: 6590887
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding acute and chronic myeloid leukaemia.
    Campbell K
    Nurs Times; 1995 Nov 22-28; 91(47):36-8. PubMed ID: 8539123
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pattern of papillary lines (dermatoglyphics) in patients with leukemia].
    Aleksandrowicz J; Debski T; Schiffer Z
    Pol Arch Med Wewn; 1969 Jul; 43(1):991-8. PubMed ID: 5259245
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic myeloid leukemia ].
    Goudemand M
    Lille Med; 1968 Apr; 13(4):477-85. PubMed ID: 5245923
    [No Abstract]   [Full Text] [Related]  

  • 29. [Zitostop therapy of chronic myeloid leukemia].
    Nagy G; Balázs C; Petrányi G
    Orv Hetil; 1971 Sep; 112(39):2352-4. PubMed ID: 5289109
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunoglobulin levels and complement system activity in leukemia].
    Kiersnowska-Rogowska B; Pietruska Z; Hryszko S; Bielawiec M
    Pol Tyg Lek; 1981 Feb; 36(6):213-6. PubMed ID: 6945567
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heterogeneity of granulocyte chemiluminescence in chronic myeloid leukemia].
    Ohnishi M; Shibata A; Shinada S
    Rinsho Ketsueki; 1984 Sep; 25(9):1402-7. PubMed ID: 6596450
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of CD117 expression on leukemia cells].
    Shen HQ; Tang YM; Yang SL; Qian BQ; Song H; Shi SW; Xu WQ
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):228-30. PubMed ID: 12859870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic myelogenous leukaemia. Report of a series of 207 patients].
    Cervantes F; Rozman C; Ballesta F; Bladé J; Brugués R; Feliu E; Grañena A; Marín P; Montserrat E; Nomdedeu B; Salguero R
    Sangre (Barc); 1983; 28(2):140-50. PubMed ID: 6576488
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of busulphan non-responsive chronic myeloid leukaemia.
    Roul RK; Singh AD
    J Indian Med Assoc; 1982 Aug; 79(3):27-9. PubMed ID: 6960081
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
    Arimori S; Nagao T; Shimizu Y; Watanabe K; Komatsuda M
    Tokai J Exp Clin Med; 1980 Jan; 5(1):63-71. PubMed ID: 6930119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytologic characteristics of blastic crisis in chronic myeloleukemia].
    Terent'eva EI; Korenevskaia MI; Kozinets GI; Mokeeva RA; Dul'tsina SM
    Probl Gematol Pereliv Krovi; 1971 Jul; 16(7):16-23. PubMed ID: 5288234
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blast crisis in chronic myeloid leukemia].
    Fink R; Höche D; Wutke K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):517-25. PubMed ID: 6196268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance in acute myeloid leukemia (AML) of bcl-2 protein expression.
    Díez-Martin JL; Gayoso J; Romero R
    Haematologica; 1997; 82(6):729-30. PubMed ID: 9499680
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of some factors on survival time in chronic myeloid leukemia].
    Voglová J; Chrobák L; Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(3):259-70. PubMed ID: 6969430
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lysozyme activities in various leukemias--with special reference to monocytic leukemia].
    Ota H; Nagase H
    Saishin Igaku; 1971 Dec; 26(12):2386-93. PubMed ID: 5290940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.